Glucoraphanin

DB15436InvestigationalSmall molecule

Glucoraphanin is under investigation in clinical trial NCT01879878 (Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]).

Mechanism: Pharmacologically active on Nuclear factor erythroid 2-related factor 2
Curator reviewed
Formula / weight: C₁₂H₂₃NO₁₀S₃ · 437.49 g/mol (avg)
Also known as: 4-methylsulfinylbutyl glucosinolate · Glucorafanin · Sulforaphane glucosinolate

Resolves to

Compound

UNIIQ86A197713CAS1432982-77-8

Structure

InChIKeyGMMLNKINDDUDCF-RFOBZYEESA-NSMILESC[S+]([O-])CCCC\C(S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)=N/OS(O)(=O)=O

Targets

Q16236NFE2L2

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Glucoraphanin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account